(NASDAQ: BLLN) Billiontoone's forecast annual revenue growth rate of 15.59% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.53%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.33%.
Billiontoone's revenue in 2026 is $436,870,000.On average, 10 Wall Street analysts forecast BLLN's revenue for 2026 to be $22,387,771,521, with the lowest BLLN revenue forecast at $21,293,249,754, and the highest BLLN revenue forecast at $23,326,069,536. On average, 10 Wall Street analysts forecast BLLN's revenue for 2027 to be $28,113,587,054, with the lowest BLLN revenue forecast at $25,951,775,182, and the highest BLLN revenue forecast at $29,747,009,107.
In 2028, BLLN is forecast to generate $31,874,423,089 in revenue, with the lowest revenue forecast at $18,774,559,767 and the highest revenue forecast at $39,127,600,512.